NeurogesX, Inc. (NASDAQOTCBB:NGSX)

CAPS Rating: 2 out of 5

A biopharmaceutical company, which focused on developing and commercializing novel pain management therapies.

No one has written a Pitch for NGSX yet. Tell us why you think NGSX will outperform or underperform the market.

Featured Broker Partners


Advertisement